On July 4, 2026, Brazil’s health regulator ANVISA issued Resolução RDC No. 45/2026, introducing a new import compliance requirement for brake pads made with asbestos substitute fibers such as ceramic, steel fiber, and aramid. From October 1, 2026, these products must be accompanied by a toxicological assessment report issued by an ISO/IEC 17025 accredited laboratory. For manufacturers, exporters, importers, testing providers, and procurement teams, this is worth close attention because the rule directly affects customs documentation, shipment release risk, and delivery planning.
The confirmed facts are limited but commercially important. ANVISA published Resolução RDC No. 45/2026 on July 4, 2026. The measure applies to imported brake pads containing asbestos substitute materials, including ceramic, steel fiber, and aramid. Starting on October 1, 2026, these products must be submitted with a toxicological assessment report from an ISO/IEC 17025 accredited laboratory. The summary provided states that the report must cover six indicators, including dust inhalation toxicity and skin sensitization. If the report is not submitted, the products will be treated as high-risk consumer goods and may face port inspection and batch detention.
From an industry perspective, importers and direct trading companies are the first group exposed to the rule because the requirement is tied to entry documentation and border treatment. The main impact is likely to fall on pre-shipment document readiness, customs submission files, and the risk of delayed release where supporting toxicology records are missing or incomplete.
Manufacturers supplying the Brazilian market may be affected because the rule is product-specific and linked to the material profile of imported brake pads. Analysis shows that compliance work may shift upstream into formulation review, laboratory coordination, and technical file preparation before goods are dispatched, especially where substitute fibers such as ceramic, steel fiber, or aramid are involved.
For procurement teams and supply chain service providers, the practical issue is not only whether the brake pad can be sourced, but whether it can be delivered with the required report from a qualified laboratory. What deserves closer attention is the supplier’s ability to provide compliant test documentation in time for shipment, because any gap may affect lead time, booking arrangements, and batch acceptance at destination.
Testing laboratories and compliance service firms may also see a more immediate role in transaction support. The requirement specifically references ISO/IEC 17025 accredited laboratories, so laboratory qualification becomes part of the commercial compliance chain rather than a background technical matter. For market participants, that raises the importance of verifying both the report content and the status of the issuing laboratory before shipment.
Companies handling exports or imports of brake pads for Brazil should review whether their current technical and compliance files already contain toxicology evidence that corresponds to the new requirement. Observably, the issue is not only product composition, but also whether documentation is formatted and issued in a way that can support import clearance after October 1, 2026.
The rule summary specifically refers to ISO/IEC 17025 accredited laboratories. Analysis shows that companies should pay attention to laboratory selection early in the shipment cycle, because a report from a laboratory that does not meet the stated accreditation condition may create avoidable trade risk even if testing has already been completed.
For orders intended for the Brazilian market, delivery and booking plans deserve closer attention around the implementation date. It is more appropriate to understand this as a timing-sensitive compliance change: shipments moving close to October 1, 2026 may require closer review of document completeness before dispatch, particularly if customs release depends on the report being available at entry.
The provided information confirms the new requirement and its enforcement consequence, but it does not provide detailed operating guidance beyond that. For that reason, companies should continue monitoring how the rule is reflected in customs practice, importer filing requirements, tender documents, and buyer documentation requests rather than assuming that all execution details are already settled.
Analysis shows that this development is more than a general regulatory statement because it sets both a clear effective date and a stated enforcement consequence for non-submission. At the same time, it would be premature to treat every practical detail as fully defined based only on the information provided here. It is more appropriate to understand this as a rule that has entered the implementation stage, while the exact market handling, documentation expectations, and transaction routines still deserve continued observation.
At this stage, the ANVISA measure is best read as a concrete compliance change for imported brake pads using asbestos substitute fibers, with direct implications for trade documentation and shipment risk into Brazil. The immediate significance lies less in broad market speculation and more in the operational requirement to align testing, accredited laboratory support, and import paperwork before the October 2026 deadline. Observably, this is a live execution issue, but market participants should remain cautious about assuming more detail than the current information confirms.
This article is based on the user-provided news title, event date, and event summary. For developments of this kind, relevant source categories typically include official regulatory notices, releases from supervisory authorities, customs or trade administration updates, industry association notices, standard-setting documents, and reporting from established trade media. No direct official source link was provided in the input, so the underlying publication record and any follow-up implementation text still need ongoing verification. What should continue to be monitored includes execution guidance, certification and testing interpretation, import document practice, tender document changes, industry feedback, and how companies implement the requirement in actual shipments.